Research & Education

Significant Discrepancies between FISH and IHC Results for ALK Testing

Results Support Need for Combined Testing

DENVER –The findings of a recent study indicate that routine testing with both fluorescent in situ hybridization (FISH) and immunohistochemistry (IHC) may enhance the detection of ALK-positive non-small cell lung cancer (NSCLC).

High Frequency of EGFR Mutations Found in Asian Population

High Rate across all Asian Subgroups

DENVER – Adenocarcinoma histology, female sex, never-smoking status, and Asian ethnicity have been considered the most important factors associated with EGFR mutations in non-small cell lung cancer and response to EGFR inhibitors.

Clinical Trial Success Influenced by Biomarker- and Receptor-Targeted Therapies in NSCLC

DENVER – Over the past decade, a great clinical focus has been directed at developing new and innovative therapies for advanced non-small cell lung cancer (NSCLC).

CEO Statement - IASLC Applauds US Pharmacy’s Decision to Stop Selling Tobacco Products

Aurora, CO – CVS Caremark, a US-based pharmacy chain, announced Wednesday it will stop selling cigarettes and other tobacco products at its CVS/pharmacy stores by October 1.

Study Shows that Gene Signature Identifies High-Risk Patients with Early-Stage NSCLC

DENVER – Researchers have shown that testing for a specific collection of genes in early-stage non-small-cell lung cancer (NSCLC) tissue accurately predicts prognosis.

Early Study Suggests Sputum-Based Biomarkers May Add to Benefit of Screening

Testing May Improve Diagnosis of Lung Cancer in Smokers

DENVER – Researchers have found that analysis of microRNAs (miRNAs) in sputum increases the specificity of lung cancer screening with low-dose spiral computed tomography (LDCT).